Ahmedabad-based Intas is developing a vaccine similar to the country's first plasma therapy

Ahmedabad-based Intas is developing a vaccine similar to the country's first plasma therapy

 The company claims that the vaccine does not require plasma therapy The company has received approval for human testing for the vaccine, and tests will begin in a month.

Intas Pharma has received approval from the Drug Controller General of India (DCGI), who sought approval for clinical trials of its specific hyperimmune globulin to treat patients with moderate to severe COVID infections. Which has been approved?

Developed a special hyperimmune globulin vaccine system

Hyperimmune globulin is used as prophylaxis for all high-risk populations exposed to corona patients. This can be an important treatment that can potentially help fight the disease until a vaccine is available. Intas is the first company in the world to adopt this approach to the treatment of corona patients.

Intus will initiate Corporate Social Responsibility (CSR) in collaboration with all Indian blood banks, which will help achieve assured plasma, the company said in a statement. .

The company said in a statement that it would produce pure and rich antibodies free of hyperimmune globulin, blood-infected viruses, and other plasma protein-free antibodies for Covid-19 patients. With the many benefits of specially formulated antibody-specific treatments, the patient does not need to choose a specific match or donor of any blood group. Unlike the usual treatment of plasma therapy, hyperimmune globulin can be easily delivered to patients in remote areas of the country.



What is the treatment of hyperimmune globulin?

As soon as a person is exposed to the virus, his body's immune system is activated. This system makes antibodies in the body. Antibodies can be especially helpful in this case to a person who has recovered from the corona. Plasma is drawn from his blood and injected into another person's body. Intas has developed a drug called Hyperimmune Globulin based on this.

Intas wants to build a network of plasma donors

Intas Medical and research institutes are establishing links with blood donation groups to collect plasma from healing patients. There are also plans to launch a website to help Corona patients find the nearest bloodbank, where they can safely donate plasma.